首页> 外文会议>Falk Workshop >Cancer in inflammatory bowel disease: frequency and clinical presentation
【24h】

Cancer in inflammatory bowel disease: frequency and clinical presentation

机译:炎症性肠病癌症:频率和临床介绍

获取原文

摘要

Links between cancer and inflammation were first identified almost 200 years ago when it was observed that tumours developed at sites of chronic inflammation and inflammatory cells were found in various tumours. Since this time, and especially recently, several lines of evidence have supported a clear relationship between chronic inflammation and cancer. It is estimated that overall 15-20% of all malignancies worldwide are associated with infection and chronic inflammation. There are many stimuli that cause inflammation and subsequent cancer, such as Helicobacter pylori-related gastric cancer or lymphoma, inflammatory bowel disease (IBD)-related colorectal cancer (CRC) or chronic prostatitis associated with prostate cancer. Not surprisingly, treatment with non-steroidal anti-inflammatory agents decreases the incidence of certain cancers such as breast cancer or CRC, not only supporting a role for inflammatory processes in several types of cancer but also showing that anti-inflammatory strategies might prevent the development into cancer as a consequence of chronic inflammation.
机译:在观察到在各种肿瘤中发现慢性炎症和炎症细胞部位开发的肿瘤的癌症和炎症之间的联系是首次鉴定的。自此此时,特别是最近,几种证据支持慢性炎症和癌症之间的明显关系。据估计,全球所有恶性肿瘤的总体15-20%与感染和慢性炎症有关。存在许多刺激引起炎症和随后的癌症,例如幽门螺杆菌相关的胃癌或淋巴瘤,炎症性肠病(IBD)相关结直肠癌(CRC)或与前列腺癌相关的慢性前列腺炎。毫不奇怪,非甾体类抗炎剂的治疗降低了某些癌症的发病率,如乳腺癌或CRC,不仅支持炎症过程在几种类型的癌症中的作用,而且表明抗炎策略可能会阻止发展作为慢性炎症的结果进入癌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号